GCM
ABMD

Geneva Capital Management’s Abiomed Inc ABMD Stock Holding History

Geneva Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-89,179
Closed -$21.9M – 129
2022
Q3 		$21.9M Sell
89,179
-1,247
-1% -$337K 0.51% 75
2022
Q2 		$22.4M Sell
90,426
-812
-0.9% -$219K 0.52% 77
2022
Q1 		$30.2M Sell
91,238
-1,557
-2% -$479K 0.58% 72
2021
Q4 		$33.3M Sell
92,795
-3,255
-3% -$1.1M 0.54% 76
2021
Q3 		$31.3M Sell
96,050
-4,871
-5% -$1.65M 0.53% 79
2021
Q2 		$31.5M Sell
100,921
-3,662
-4% -$1.12M 0.51% 81
2021
Q1 		$33.3M Sell
104,583
-5,003
-5% -$1.6M 0.57% 74
2020
Q4 		$35.5M Sell
109,586
-12,363
-10% -$3.42M 0.6% 70
2020
Q3 		$33.8M Sell
121,949
-6,608
-5% -$1.9M 0.7% 65
2020
Q2 		$31.1M Sell
128,557
-2,302
-2% -$462K 0.67% 67
2020
Q1 		$19M Buy
+130,859
New +$21.7M 0.54% 76
2014
Q3 		$16.5M Sell
666,378
-11,638
-2% -$295K 0.48% 74
2014
Q2 		$17M Buy
678,016
+43,170
+7% +$1M 0.42% 76
2014
Q1 		$16.5M Buy
634,846
+79,513
+14% +$2.2M 0.39% 75
2013
Q4 		$14.8M Buy
555,333
+219,431
+65% +$5.42M 0.34% 85
2013
Q3 		$6.4M Buy
+335,902
New +$7.68M 0.15% 102

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Geneva Capital Management's ABMD Position: Q4 2022 in Review

Geneva Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 89,179 shares — an estimated $21.9M sold.

Geneva Capital Management first reported a position in ABMD in Q3 2013 and held it in 16 quarters. The position peaked at $35.5M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Geneva Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Geneva Capital Management sold 89,179 Abiomed Inc shares in Q4 2022, an estimated $21.9M.
  • Geneva Capital Management first reported a position in Abiomed Inc in Q3 2013 and held it in 16 quarters.
  • Geneva Capital Management's Abiomed Inc position peaked at $35.5M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Geneva Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.